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Abstract
Background: Pharmacological management of cervical dystonia (CD) is considered to be symptomatic in effect, rather than targeting the underlying patho-
physiology of the disease. Magnetoencephalography (MEG), a direct measure of neuronal activity, while accepted as a modality for pre-surgical mapping in epilepsy,
has never been used to explore the effect of pharmacotherapy in movement disorders.
Methods: Resting state MEG data were collected from patients with CD, pre- and post-botulinum toxin injections. All of these patients exhibited good clinical
benefit with botulinum toxin. Resting state MEG data from four age- and gender-matched healthy controls with no neurological disorders were also collected.
Results: Our exploratory study reveals a difference in coherence between controls and patients in the following regions: fronto-striatal, occipito-striatal, parieto-
striatal, and striato-temporal networks. In these regions there is an increase after botulinum toxin. Specifically, increased coherence in the left putamen and right
superior parietal gyrus was noticeable. Both intrahemispheric and interhemispheric networks were affected.
Discussion: This is the first attempt to directly assess changes in functional connectivity with pharmacotherapy using MEG. Botulinum toxin might affect sensorimotor
integration, leading to clinical benefit. The presence of increased interhemispheric coherence and intrahemispheric coherence points to the importance of global and local
networks in the pathophysiology of dystonia.
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Introduction
Dystonia is described as a varied pattern of sustained involuntary
movement characterized by overactivity of muscles, often associated
with voluntary movement. While the etiology may be initially attribu-
ted to a psychiatric condition, it is now clear this is a movement
disorder. In fact, in 1986 abnormal activity in the basal ganglia-
thalamocortical circuits was proposed as the underlying pathogenesis
of disorders of motor function.1 More recently, studies have indicated
that reduced intracortical inhibition and distorted somatotopic cortical
representation in the somatosensory cortex play a critical role in the
pathogenesis of dystonia.2 Using fludeoxyglucose positron emission
tomography (FDG-PET) and diffusion tensor imaging (DTI), Carbon
et al.3 described aberrant fronto-striatal connectivity and cerebellar
involvement in the disease mechanism of hereditary dystonia. Other
studies using functional MRI (fMRI) in cervical dystonia (CD) patients
revealed altered functional connectivity within the sensorimotor, the
executive control, and the primary visual networks.4
While there is no known cure for dystonia, medications can often
reduce the sustained contraction, thereby providing relief. Pharmaco-
logical management of dystonia, including muscle relaxants, botulinum
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toxin injections, and benzodiazepines are thought to be symptomatic
in effect, rather than targeting the underlying pathophysiology of
the disease.5
Magnetoencephalography-coherence source imaging (MEG-CSI)
has primarily been studied for pre-surgical mapping in patients with
focal epilepsy, with better surgical outcomes with use.6 It has never
been utilized in patients with dystonia.
In our study, we aimed to characterize functional connectivity in
patients with CD before and after treatment with botulinum toxin,
using MEG-CSI.
Methods
MEG data were collected from four patients, between the ages of
33 and 61 years, with CD (Table 1). These patients had to exhibit good
clinical benefit with botulinum toxin injections to be included in this
study. Patients were asked about the maximal benefit they experienced
from the botulinum toxin before scheduling them for a MEG study
post injection. On average, this was between 2 and 3 weeks post
injection. MEG data from four age- and gender-matched controls with
no diagnosed neurological disorder were also collected.
Resting state MEG data were acquired for 10 minutes with eyes
open, using a 148-channel whole-head magnetometer system (4D
Neuroimaging, San Diego, CA) inside a magnetically shielded room.
Two 10-minute MEG scans were obtained per patient: one pre- and
one post medication. The data were sampled at a rate of 508.6 Hz
(DC to 100 Hz, with direct coupling at zero Hz) and then were forward
and backward bandpass filtered (3–50 Hz). Changes in the subject’s
position during the study were detected by alterations in the magnetic
field locations from five coils on the forehead and in front of both ears.5
An independent component analysis (ICA) was used to filter out the
identifiable heart signals observed in the MEG recordings. Then, MEG-
CSI was performed to assess neuronal synchrony within different brain
regions.7 Post-acquisition data processing was performed using MEG
Tools, an open-source Matlab-based (Mathworks Inc., Natick, MA,
USA) software module for cortical source imaging.
MEG-CSI results were displayed on the patient’s MRI scan, which
was co-registered to the subject’s digitized head shape recorded at the
time of MEG data collection. To localize sources of coherent activity,
a model of gray matter was constructed using the individual’s
T1-weighted high-resolution volumetric MRI scan. The realistic head
model consisted of X-, Y-, and Z-oriented dipoles at approximately
4,000 locations distributed to represent the same amount of gray
matter identified in each individual’s MRI scan. Synchronization of
neuronal activity was quantified by applying a time frequency decom-
position technique, the short-time Fourier transformation (sFFT). After
transformation to a time frequency representation, the strength of
network interactions was estimated by calculating coherence, a mea-
sure of synchrony between signals from different brain regions for each
FFT frequency component. The 10 minutes of resting state MEG data
were prepared for source imaging by division into 80 segments, each
containing 7.5 seconds of data of relatively uniform brain behavior.7
For each of these data segments, signals from neuronal sources were
isolated using another ICA spatiotemporal decomposition technique
designed to extract signals from distinct compact sources that exhibit
burst behavior and minimal temporal overlap with other active
sources. These ICA signal components have MEG spatial magnetic
field patterns corresponding to one or a few spatially distinct compact
sources that are much easier to image accurately using a current
distribution source imaging technique (MR-FOCUSS).6 Separate from
the imaging algorithm, the cross-spectrum between ICA signals was
calculated. In these cross-spectrum calculations, a sequence of FFT
spectra was calculated using 0.5 second windows and 25% overlap
with FFT amplitudes for 24 frequency bins of 2 Hz width between 3
and 50 Hz. The imaging results and the signal cross-spectrum were
used to calculate the coherence between all pairings (1,431 locations in
the brain) of active cortical locations within each of 24 frequency bins.
Finally, for each active source, the average coherence across frequen-
cies and sources was calculated. In these coherence imaging results,
the localization of imaged brain activity is strongly dependent on the
frequency bands with greatest power. Coherence analysis results were
Table 1. Patient Demographics and Clinical Characteristics
Patient 1 Patient 2 Patient 3 Patient 4
Age (years) 54 61 53 33
Gender Male Female Female Female
Disease duration (years) 3 21 1 1
Diagnosis Cervical dystonia Cervical dystonia Cervical dystonia Cervical dystonia
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encoded as a color spectrum for values between 1 (entirely coherent)
and 0 (no coherence) and overlaid on the patient’s MRI with the
solutions restricted to the gray matter. A region-of-interest tool was
used to identify 54 regions in the brain (27 in each hemisphere), using
delineated anatomical structures. Anatomical identification in these
regions was implemented using MEG tools.8 Coherence results were
assessed within a given hemisphere (intrahemispheric) and between the
two hemispheres (interhemispheric).
A p-value was produced for each region pair. The false discovery
rate (FDR) was used to adjust for multiple testing. Only statistically
significant coherence values (p,0.05) with a large effect were considered.
Further, to control for the FDR, the Benjamini–Hochberg (BH)-adjusted
p-value was obtained.
This study was performed in accordance with the ethical standards
laid down in the 1964 Declaration of Helsinki and its later amendments.
All persons gave their written informed consent prior to their inclusion in
the study. No patient-identifiable information was included in the text.
Results
Pre- and post-treatment MEG data were obtained in our four patients
(Table 1, Figure 1). None of these patients was naı̈ve to botulinum toxin at
the time of the study. Prior to treatment, out of a total of 1,431 networks,
Figure 1. Patient 1, MEG Images Pre and Post Botulinum Toxin. Regions of the brain that are different pre (green) and post (red) medication in this subject
who took botulinum toxin. Red areas indicate where more coherent activity was seen after treatment. Green areas had higher coherence prior to treatment.
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11 interhemispheric networks and seven left-sided intrahemisheric
networks were statistically significantly different between the two groups
in the fronto-striatal pathway. Other pathways with a statistically
significant difference in coherence between controls and patients were
the occipito-striatal, parieto-striatal, and temporo-striatal areas, with
areas of high coherence in the interhemispheric and intrahemispheric
pathways (Figure 2).
After treatment, out of a total of 1,431 networks, 12 interhemi-
spheric networks and eight left-sided intrahemisheric networks were
statistically significantly different between the two groups in the
fronto-striatal pathway. Other pathways with a statistically signifi-
cant difference in coherence between controls and patients were
again found in the occipito-striatal, parieto-striatal, and temporo-
striatal regions, with the areas of high coherence in the interhemi-
spheric and intrahemispheric pathways (Figure 2).
With botulinum toxin, an overall increase in coherence was seen in
patients. Specifically, an increase was appreciated in each of the above-
mentioned networks. Comparing coherence in CD patients pre- and post
botulinum toxin, an increase was appreciated in the frontal–frontal,
frontal–parietal, frontal–temporal, and cingulate–occipital pathways with
botulinum toxin (Figure 2).
With BH adjustment, significant differences in coherence between
controls and patients were seen in the following areas, prior to botu-
linum toxin injections: left cingulate gyrus–left putamen, left putamen–
right inferior frontal gyrus, and left putamen–right inferior occipital
gyrus (Figure 3). With botulinum toxin, significant differences in coherence
between controls and patients was seen in the above-mentioned areas,
along with an additional region of difference in coherence: the left
putamen–right superior parietal gyrus (Figure 3).
Discussion
To our knowledge, this is the first study using MEG to explore
functional networks in patients with CD. It is also the first MEG study
to assess the effect of botulinum toxin on these networks.
Botulinum toxin is believed to have a symptomatic benefit in dystonia
with no effect on the underlying pathophysiology. Our exploratory study
reveals increased overall coherence, specifically in the fronto-striatal,
occipito-striatal, parieto-striatal, and striato-temporal networks follow-
ing treatment. Comparing coherence in CD patients, an increase was
appreciated in the frontal–frontal, frontal–parietal, frontal–temporal, and
cingulate–occipital pathways. These results may indicate a central mecha-
nism to the clinical benefit. In addition, the presence of increased inter-
hemispheric coherence, apart from intrahemispheric coherence, perhaps
points toward the importance of global and local networks in the patho-
physiology of dystonia.
Several studies have suggested the fronto-striatal network is associa-
ted with executive function while the occipito-striatal network represents
visuospatial function.1,3,4 In our study, the difference in coherence, prior
to botulinum toxin, between controls and patients was seen in the above-
mentioned cortico-striatal pathways. This may indicate the underlying
pathophysiology of CD.
The importance of executive dysfunction in movement disorders is
well recognized.9 In fact, recent studies have expanded the under-
standing of visuospatial cognitive dysfunction in the pathology of
dystonia, albeit with other neuroimaging modalities.3,4,10 While our
study is not powered to comment on individual cognitive pathways
in CD, this should be looked into in future studies.
In our clinical applications for epilepsy pre-surgical mapping,
we found that using a 3 Hz high pass filter removes any breathing
artifacts. We also found that using a 50 Hz low pass filter provides all
the power in the data without any impact from the 60 Hz power lines.
Future studies could open up the filter to a low pass of 100 Hz to
determine if there is anything in the high gamma range that is different
from that reported here.
BH adjustment of p-values lowers the false-positive rate and, there-
fore, allows for more stringent assessment of statistically significant
coherence between two regions. With botulinum toxin, coherence
between CD patients and controls became statistically significant in
the following regions: left putamen and right superior parietal gyrus.
The superior parietal lobule integrates multiple sensory inputs into a
single spatial frame. It is associated with multisensory-motor integra-
tion and spatial attention in humans.11 Our analysis indicates that the
clinical benefit seen with botulinum toxin in CD patients might relate
to improvement of sensorimotor integration.
Other studies have employed MEG to study dystonia. In a recent
report assessing focal dystonia, patients showed reduced efficiency
of inhibition in sensory areas. Further MEG analysis demonstrated
decreased responsiveness to sensory thalamocortical inflow in primary
and cortical areas.12 In another MEG dystonia study, MEG revealed
abnormal somatosensory reorganization in musician’s dystonia.13 Our
study is unique in that it utilized MEG-CSI to evaluate treatment
responses in CD.
MEG offers several advantages when assessing functional cortical
networks. Specifically, MEG is a direct measurement of neuronal
activity with high temporal and spatial resolution. Unlike MEG using
sensor space, MEG-CSI using source space localization does indeed
have great spatial resolution for cortical imaging.14 Our source space
coherence is performed after current distribution imaging has been
performed. This negates the issue of current spread that would be
the reason for poor spatial resolution of sensor space coherence. Our
MEG laboratory sensor is a magnetometer-type system that is found
to have better resolution for deeper structures.
Other functional neuroimaging studies such as positron emission
tomography and fMRI may offer high spatial resolution but they are
indirect measurements of brain activity—specifically, changes in meta-
bolic responses and blood flow, respectively. These indirect measure-
ments may offer less precise temporal resolution.
Although these results have illustrated changes in functional net-
works pre- and post-botulinum toxin, with the small sample size it is
not feasible to comment on potential variation in the mechanism of
action of the three treatment regimens used in this study. Further, our
study does not employ validated rating scales to quantify the above-
mentioned change in motor and potentially non-motor functionality
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Figure 2. Difference in Coherence between Patients and Controls, Pre and Post-Botulinum Toxin. (A) The biggest difference in coherence seen in the
fronto-striatal, occipito-striatal, parieto-striatal, and temporo- striatal areas in controls compared with patients. (B) With botulinum toxin, there is an increase in
coherence overall in the above-mentioned pathways in controls compared with patients. (C) Comparing cervical dystonia patients, coherence networks increased
after medication, especially in the frontal–frontal, frontal–parietal, frontal–temporal, and cingulate–occipital pathways.
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Figure 3. Difference in Coherence between Patients and Controls, Pre and Post Botulinum Toxin, using BH Correction. Using Benjamini–
Hochberg adjustment, significant differences in coherence between patients and controls were seen in the following regions: left cingulate gyrus–left putamen,
left putamen–right inferior frontal gyrus, left putamen–right inferior occipital gyrus. With botulinum toxin, additionally, a significant difference was seen in the
left putamen–right superior parietal gyrus.
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with botulinum toxin injections. While 1,431 network connections
were assessed per patient using MEG, repetition of results with a larger
sample size would be ideal to explore potential differences between
medications with varying mechanisms of action.
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